Infectious Disease / Microbiology Updates
رفتن به کانال در Telegram
All the atest articles, research and news from worlds leading Infectious Disease Journals. Discussion group https://t.me/Professional_Medical_Discussion
نمایش بیشتر7 806
مشترکین
+324 ساعت
+297 روز
+20230 روز
در حال بارگیری داده...
کانالهای مشابه
ابر برچسبها
اشارات ورودی و خروجی
---
---
---
---
---
---
جذب مشترکین
اوت '26
اوت '26
+242
در 0 کانالها
ژوئیه '26
+357
در 0 کانالها
Get PRO
ژوئن '26
+282
در 0 کانالها
Get PRO
مه '26
+332
در 0 کانالها
Get PRO
آوریل '26
+290
در 0 کانالها
Get PRO
مارس '26
+159
در 0 کانالها
Get PRO
فوریه '26
+244
در 0 کانالها
Get PRO
ژانویه '26
+245
در 0 کانالها
Get PRO
دسامبر '25
+204
در 0 کانالها
Get PRO
نوامبر '25
+247
در 2 کانالها
Get PRO
اکتبر '25
+81
در 1 کانالها
Get PRO
سپتامبر '25
+17
در 0 کانالها
Get PRO
اوت '25
+25
در 0 کانالها
Get PRO
ژوئیه '25
+31
در 1 کانالها
Get PRO
ژوئن '25
+18
در 0 کانالها
Get PRO
مه '25
+17
در 0 کانالها
Get PRO
آوریل '25
+37
در 0 کانالها
Get PRO
مارس '25
+30
در 0 کانالها
Get PRO
فوریه '25
+12
در 0 کانالها
Get PRO
ژانویه '25
+26
در 2 کانالها
Get PRO
دسامبر '24
+107
در 0 کانالها
Get PRO
نوامبر '24
+450
در 0 کانالها
Get PRO
اکتبر '24
+436
در 0 کانالها
Get PRO
سپتامبر '24
+389
در 1 کانالها
Get PRO
اوت '24
+297
در 0 کانالها
Get PRO
ژوئیه '24
+532
در 3 کانالها
Get PRO
ژوئن '240
در 0 کانالها
Get PRO
مه '24
+77
در 1 کانالها
Get PRO
آوریل '24
+141
در 0 کانالها
Get PRO
مارس '24
+162
در 0 کانالها
Get PRO
فوریه '24
+187
در 0 کانالها
Get PRO
ژانویه '24
+293
در 0 کانالها
Get PRO
دسامبر '23
+319
در 0 کانالها
Get PRO
نوامبر '23
+156
در 0 کانالها
Get PRO
اکتبر '23
+260
در 1 کانالها
Get PRO
سپتامبر '23
+167
در 0 کانالها
Get PRO
اوت '23
+91
در 0 کانالها
Get PRO
ژوئیه '23
+85
در 0 کانالها
Get PRO
ژوئن '23
+93
در 0 کانالها
Get PRO
مه '23
+80
در 0 کانالها
Get PRO
آوریل '23
+88
در 0 کانالها
Get PRO
مارس '23
+103
در 0 کانالها
Get PRO
فوریه '23
+74
در 0 کانالها
Get PRO
ژانویه '23
+90
در 0 کانالها
Get PRO
دسامبر '22
+89
در 0 کانالها
Get PRO
نوامبر '22
+227
در 0 کانالها
Get PRO
اکتبر '22
+75
در 0 کانالها
Get PRO
سپتامبر '22
+134
در 0 کانالها
Get PRO
اوت '22
+90
در 0 کانالها
Get PRO
ژوئیه '22
+65
در 0 کانالها
Get PRO
ژوئن '22
+126
در 0 کانالها
Get PRO
مه '22
+118
در 0 کانالها
Get PRO
آوریل '22
+75
در 0 کانالها
Get PRO
مارس '22
+59
در 0 کانالها
Get PRO
فوریه '22
+33
در 0 کانالها
Get PRO
ژانویه '22
+46
در 0 کانالها
Get PRO
دسامبر '21
+47
در 0 کانالها
Get PRO
نوامبر '21
+37
در 0 کانالها
Get PRO
اکتبر '21
+59
در 0 کانالها
Get PRO
سپتامبر '21
+52
در 0 کانالها
Get PRO
اوت '21
+65
در 0 کانالها
Get PRO
ژوئیه '21
+68
در 0 کانالها
Get PRO
ژوئن '21
+77
در 0 کانالها
Get PRO
مه '21
+57
در 0 کانالها
Get PRO
آوریل '21
+190
در 0 کانالها
Get PRO
مارس '21
+166
در 0 کانالها
Get PRO
فوریه '21
+36
در 0 کانالها
Get PRO
ژانویه '21
+35
در 0 کانالها
Get PRO
دسامبر '20
+495
در 0 کانالها
| تاریخ | رشد مشترکین | اشارات | کانالها | |
| 28 اوت | +9 | |||
| 27 اوت | +7 | |||
| 26 اوت | +10 | |||
| 25 اوت | +6 | |||
| 24 اوت | +5 | |||
| 23 اوت | +10 | |||
| 22 اوت | +3 | |||
| 21 اوت | +10 | |||
| 20 اوت | +15 | |||
| 19 اوت | +14 | |||
| 18 اوت | +6 | |||
| 17 اوت | +5 | |||
| 16 اوت | +4 | |||
| 15 اوت | +8 | |||
| 14 اوت | +14 | |||
| 13 اوت | +5 | |||
| 12 اوت | +12 | |||
| 11 اوت | +8 | |||
| 10 اوت | +19 | |||
| 09 اوت | +7 | |||
| 08 اوت | +11 | |||
| 07 اوت | +9 | |||
| 06 اوت | +8 | |||
| 05 اوت | +5 | |||
| 04 اوت | +11 | |||
| 03 اوت | +10 | |||
| 02 اوت | +7 | |||
| 01 اوت | +4 |
پستهای کانال
Monkeypox Virus Surveillance in Wastewater, North Carolina, USA, October 2023–May 2025
https://wwwnc.cdc.gov/eid/article/32/13/26-0414_article
| 2 | [Correspondence] Occupational HIV monitoring should match standard of care
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00200-6/fulltext?rss=yes
A health-care worker in England who lives with HIV and performs exposure-prone procedures must, under UK Health Security Agency (UKHSA) guidance, have their plasma viral load measured every 12 weeks for the rest of their working life.1 Were the same person a patient rather than a practitioner, British HIV Association guidance would support monitoring as infrequently as every 6 months once they were stable and suppressed.2 Same virus, same therapy, same undetectable viral load, twice the surveillance, indefinitely, and applied to one protected group. | 309 |
| 3 | [Editorial] Will the new UN political declaration deliver?
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00205-5/fulltext?rss=yes
On June 23, the UN General Assembly concluded its high-level meeting on HIV/AIDS with a new Political Declaration on HIV/AIDS, the culmination of negotiations among member states and stakeholders involved with the HIV response. The declaration reaffirmed the overarching commitment to end HIV/AIDS by 2030 and to ensure a sustainable HIV response beyond 2030. The declaration was endorsed by 149 member states. Eight countries—Burkina Faso, Burundi, Israel, Niger, North Korea, Russia, Senegal, and the USA—voted against it, and 14 (mainly among countries in the Middle East) abstained. | 289 |
| 4 | [Feature] Highlights of AIDS 2026
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00203-1/fulltext?rss=yes
Long-acting and weekly regimens for HIV treatment and prevention shared the stage with results of disruptions to PEPFAR in Rio de Janeiro, Brazil, July 26–31. Adrian Gonzalez Lopez reports. | 217 |
| 5 | [Review] Evolving understanding of Kaposi sarcoma and associated diseases in the ART era
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00110-4/fulltext?rss=yes
Kaposi sarcoma (KS)-associated herpesvirus (KSHV), otherwise known as HHV-8, causes KS and several lymphoproliferative disorders including KSHV-associated multicentric Castleman disease, KSHV-associated inflammatory cytokine syndrome, primary effusion lymphoma, and KSHV-positive diffuse large B-cell lymphoma not otherwise specified. KS represents a substantial burden of disease in sub-Saharan Africa and in people with HIV worldwide. Diagnosis relies on pathology, but quantitative KSHV DNA measurements can help identify multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome and monitor treatment response. | 259 |
| 6 | [Articles] Interventions to improve viral suppression and adherence to antiretroviral therapy among people living with HIV: a systematic review and network meta-analysis
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(26)00119-0/fulltext?rss=yes
Scalable adherence interventions—particularly reminders, counselling, and supporter-based approaches—improved adherence. Tailoring interventions to population needs could therefore strengthen HIV treatment outcomes and support global progress towards epidemic control. | 250 |
| 7 | Wastewater Respiratory Virus Surveillance in Remote Community, Alaska, USA, 2022–2024
https://wwwnc.cdc.gov/eid/article/32/13/26-0709_article | 456 |
| 8 | Emergence of Oropouche Virus, Venezuela, 2025
https://wwwnc.cdc.gov/eid/article/32/9/25-0678_article | 844 |
| 9 | [Correspondence] Congolese hospital staff cohort admitted with infectious symptoms in the setting of the Bundibugyo virus outbreak, April and May 2026, Bunia, DR Congo
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00420-2/fulltext?rss=yes
On May 15, 2026, DR Congo announced an outbreak of Ebola disease caused by a new variant of Bundibugyo virus in Ituri Province.1 The outbreak's epicentre was Mongbwalu, a gold mining town located 80 km from Bunia, Ituri's capital. In the 2 weeks before this announcement, Centre Medical Evangelique's Centre Hospitalier de Bunia (CME-Bunia), had received 11 patients from Mongbwalu, 63% of whom eventually died. Most had fever, diarrhoea, and vomiting, and several developed bleeding. Subsequent chart review has shown similar cases arriving as early as April 2. | 898 |
| 10 | Pulmonary Histoplasmosis, Taiwan, 1997–2024 (Response)
https://wwwnc.cdc.gov/eid/article/32/9/26-1249_article | 730 |
| 11 | Pediatric Rickettsia massiliae Infection, Spain, 2023
https://wwwnc.cdc.gov/eid/article/32/9/26-0035_article | 637 |
| 12 | Chronic Elbow Nodules Caused by Fomitiporella Fungus in Immunocompetent Patients, United States
https://wwwnc.cdc.gov/eid/article/32/9/26-0263_article | 591 |
| 13 | Temporal Alignment of Wastewater Signals with Clinical Indicators of Respiratory Illness Postpandemic, Texas, USA
https://wwwnc.cdc.gov/eid/article/32/13/26-0141_article | 738 |
| 14 | Wickerhamomyces anomalus Pseudo-Outbreak Associated with Medical Lubricating Gel, South Africa, 2023–2024
https://wwwnc.cdc.gov/eid/article/32/9/26-0608_article | 761 |
| 15 | Case Report and Retrospective Review of Acanthamoeba Encephalitis and Chronic Lymphocytic Leukemia, United States
https://wwwnc.cdc.gov/eid/article/32/9/26-0790_article | 717 |
| 16 | Dual PCR–Sanger Sequencing Assay for Simultaneous sqle-Based Identification and Resistance Detection in Trichophyton Species
https://wwwnc.cdc.gov/eid/article/32/9/26-0819_article | 647 |
| 17 | Outbreak of Brazilian Spotted Fever, Southeastern Brazil, 2018
https://wwwnc.cdc.gov/eid/article/32/9/26-0548_article | 722 |
| 18 | Correlations between Wastewater Concentrations of Influenza A and Respiratory Syncytial Viruses and Clinical Laboratory Testing and Hospitalization Data, California, USA
https://wwwnc.cdc.gov/eid/article/32/13/26-0306_article | 965 |
| 19 | Epidemiology of and Risk Factors for Amebic Meningoencephalitis, Kerala, India, 2025
https://wwwnc.cdc.gov/eid/article/32/9/26-0492_article | 1 255 |
| 20 | Improved Case Detection of Fleaborne Typhus by PCR Testing, Los Angeles County, California, USA, 2022–2024
https://wwwnc.cdc.gov/eid/article/32/9/26-0554_article | 1 172 |
